Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
CHEMICAL SYNTHESIS. Going with the flow.

Science (New York, N.Y.)

Martin RE.
PMID: 27034365
Science. 2016 Apr 01;352(6281):44-5. doi: 10.1126/science.aaf3065.

No abstract available.

Cite
Martin RE. CHEMICAL SYNTHESIS. Going with the flow. Science. 2016;352(6281):44-5doi: 10.1126/science.aaf3065.
Martin, R. E. (2016). CHEMICAL SYNTHESIS. Going with the flow. Science (New York, N.Y.), 352(6281), 44-5. https://doi.org/10.1126/science.aaf3065
Martin, Rainer E. "CHEMICAL SYNTHESIS. Going with the flow." Science (New York, N.Y.) vol. 352,6281 (2016): 44-5. doi: https://doi.org/10.1126/science.aaf3065
Martin RE. CHEMICAL SYNTHESIS. Going with the flow. Science. 2016 Apr 01;352(6281):44-5. doi: 10.1126/science.aaf3065. PMID: 27034365.
Copy Download .nbib Format: NLM
Self-assembled organic nanostructures in medicinal chemistry: advances and applications.

Current topics in medicinal chemistry

Rodrigues J, Rathi B.
PMID: 25930062
Curr Top Med Chem. 2015;15(13):1161. doi: 10.2174/1568026615666150330105539.

No abstract available.

Cite
Rodrigues J, Rathi B. Self-assembled organic nanostructures in medicinal chemistry: advances and applications. Curr Top Med Chem. 2015;15(13):1161doi: 10.2174/1568026615666150330105539.
Rodrigues, J., & Rathi, B. (2015). Self-assembled organic nanostructures in medicinal chemistry: advances and applications. Current topics in medicinal chemistry, 15(13), 1161. https://doi.org/10.2174/1568026615666150330105539
Rodrigues, Joao, and Rathi, Brijesh. "Self-assembled organic nanostructures in medicinal chemistry: advances and applications." Current topics in medicinal chemistry vol. 15,13 (2015): 1161. doi: https://doi.org/10.2174/1568026615666150330105539
Rodrigues J, Rathi B. Self-assembled organic nanostructures in medicinal chemistry: advances and applications. Curr Top Med Chem. 2015;15(13):1161. doi: 10.2174/1568026615666150330105539. PMID: 25930062.
Copy Download .nbib Format: NLM
[Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology].

Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials

Xu F, Wang LL, Shi ZQ, Chen F, Sun DM.
PMID: 26930991
Zhong Yao Cai. 2015 Sep;38(9):1969-73.

OBJECTIVE: To optimize the formulation of Zuojin floating-bioadhesive pellets by the central composite design-response surface methodology (CCD-RSM).METHODS: In the formulation design using CCD-RSM, independent variables were the amounts of sodium bicarbonate (X1), HPMC (X2) and MCC (X3) as factors....

Cite
Xu F, Wang LL, Shi ZQ, et al. [Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology]. Zhong Yao Cai. 2015;38(9):1969-73
Xu, F., Wang, L. L., Shi, Z. Q., Chen, F., & Sun, D. M. (2015). [Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 38(9), 1969-73.
Xu, Feng, et al. "[Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology]." Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials vol. 38,9 (2015): 1969-73.
Xu F, Wang LL, Shi ZQ, Chen F, Sun DM. [Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology]. Zhong Yao Cai. 2015 Sep;38(9):1969-73. Chinese. PMID: 26930991.
Copy Download .nbib Format: NLM
Preface.

Current drug delivery

Toth I.
PMID: 27447004
Curr Drug Deliv. 2016;13(1):3. doi: 10.2174/156720181301160314153150.

No abstract available.

Cite
Toth I. Preface. Curr Drug Deliv. 2016;13(1):3doi: 10.2174/156720181301160314153150.
Toth, I. (2016). Preface. Current drug delivery, 13(1), 3. https://doi.org/10.2174/156720181301160314153150
Toth, Istvan. "Preface." Current drug delivery vol. 13,1 (2016): 3. doi: https://doi.org/10.2174/156720181301160314153150
Toth I. Preface. Curr Drug Deliv. 2016;13(1):3. doi: 10.2174/156720181301160314153150. PMID: 27447004.
Copy Download .nbib Format: NLM
Technical Advances in Medicinal Chemistry.

ACS combinatorial science

Finn MG.
PMID: 28374995
ACS Comb Sci. 2017 May 08;19(5):277-278. doi: 10.1021/acscombsci.7b00053. Epub 2017 Apr 04.

No abstract available.

Cite
Finn MG. Technical Advances in Medicinal Chemistry. ACS Comb Sci. 2017;19(5):277-278doi: 10.1021/acscombsci.7b00053.
Finn, M. G. (2017). Technical Advances in Medicinal Chemistry. ACS combinatorial science, 19(5), 277-278. https://doi.org/10.1021/acscombsci.7b00053
Finn, M G. "Technical Advances in Medicinal Chemistry." ACS combinatorial science vol. 19,5 (2017): 277-278. doi: https://doi.org/10.1021/acscombsci.7b00053
Finn MG. Technical Advances in Medicinal Chemistry. ACS Comb Sci. 2017 May 08;19(5):277-278. doi: 10.1021/acscombsci.7b00053. Epub 2017 Apr 04. PMID: 28374995.
Copy Download .nbib Format: NLM
[Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Tokiwa H.
PMID: 26329543
Yakugaku Zasshi. 2015;135(9):1001-2. doi: 10.1248/yakushi.15-00175-F.

No abstract available.

Cite
Tokiwa H. [Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]. Yakugaku Zasshi. 2015;135(9):1001-2doi: 10.1248/yakushi.15-00175-F.
Tokiwa, H. (2015). [Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 135(9), 1001-2. https://doi.org/10.1248/yakushi.15-00175-F
Tokiwa, Hiroaki. "[Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]." Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan vol. 135,9 (2015): 1001-2. doi: https://doi.org/10.1248/yakushi.15-00175-F
Tokiwa H. [Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]. Yakugaku Zasshi. 2015;135(9):1001-2. doi: 10.1248/yakushi.15-00175-F. Japanese. PMID: 26329543.
Copy Download .nbib Format: NLM
Embedding sustainable practices into pharmaceutical R&D: what are the challenges?.

Future medicinal chemistry

Sneddon H.
PMID: 25329193
Future Med Chem. 2014;6(12):1373-6. doi: 10.4155/fmc.14.91.

No abstract available.

Cite
Sneddon H. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?. Future Med Chem. 2014;6(12):1373-6doi: 10.4155/fmc.14.91.
Sneddon, H. (2014). Embedding sustainable practices into pharmaceutical R&D: what are the challenges?. Future medicinal chemistry, 6(12), 1373-6. https://doi.org/10.4155/fmc.14.91
Sneddon, Helen. "Embedding sustainable practices into pharmaceutical R&D: what are the challenges?." Future medicinal chemistry vol. 6,12 (2014): 1373-6. doi: https://doi.org/10.4155/fmc.14.91
Sneddon H. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?. Future Med Chem. 2014;6(12):1373-6. doi: 10.4155/fmc.14.91. PMID: 25329193.
Copy Download .nbib Format: NLM
Role of the development scientist in compound lead selection and optimization.

Journal of pharmaceutical sciences

Venkatesh S, Lipper RA.
PMID: 10688744
J Pharm Sci. 2000 Feb;89(2):145-54. doi: 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6.

The R&D process for bringing drugs from discovery laboratories to the marketplace is undergoing rapid change, as enabled by new technologies and as demanded by the global pharmaceutical business environment. One consequence of the accelerated R&D paradigm is a...

Cite
Venkatesh S, Lipper RA. Role of the development scientist in compound lead selection and optimization. J Pharm Sci. 2000;89(2):145-54doi: 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6.
Venkatesh, S., & Lipper, R. A. (2000). Role of the development scientist in compound lead selection and optimization. Journal of pharmaceutical sciences, 89(2), 145-54. https://doi.org/10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6
Venkatesh, S, and Lipper, R A. "Role of the development scientist in compound lead selection and optimization." Journal of pharmaceutical sciences vol. 89,2 (2000): 145-54. doi: https://doi.org/10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6
Venkatesh S, Lipper RA. Role of the development scientist in compound lead selection and optimization. J Pharm Sci. 2000 Feb;89(2):145-54. doi: 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6. PMID: 10688744.
Copy Download .nbib Format: NLM
Chris Lipinski discusses life and chemistry after the Rule of Five.

Drug discovery today

Lipinski CA.
PMID: 12546981
Drug Discov Today. 2003 Jan 01;8(1):12-6. doi: 10.1016/s1359-6446(02)02556-4.

No abstract available.

Cite
Lipinski CA. Chris Lipinski discusses life and chemistry after the Rule of Five. Drug Discov Today. 2003;8(1):12-6doi: 10.1016/s1359-6446(02)02556-4.
Lipinski, C. A. (2003). Chris Lipinski discusses life and chemistry after the Rule of Five. Drug discovery today, 8(1), 12-6. https://doi.org/10.1016/s1359-6446(02)02556-4
Lipinski, Christopher A. "Chris Lipinski discusses life and chemistry after the Rule of Five." Drug discovery today vol. 8,1 (2003): 12-6. doi: https://doi.org/10.1016/s1359-6446(02)02556-4
Lipinski CA. Chris Lipinski discusses life and chemistry after the Rule of Five. Drug Discov Today. 2003 Jan 01;8(1):12-6. doi: 10.1016/s1359-6446(02)02556-4. PMID: 12546981.
Copy Download .nbib Format: NLM
Similarity-based virtual screening using 2D fingerprints.

Drug discovery today

Willett P.
PMID: 17129822
Drug Discov Today. 2006 Dec;11(23):1046-53. doi: 10.1016/j.drudis.2006.10.005. Epub 2006 Oct 20.

This paper summarizes recent work at the University of Sheffield on virtual screening methods that use 2D fingerprint measures of structural similarity. A detailed comparison of a large number of similarity coefficients demonstrates that the well-known Tanimoto coefficient remains...

Cite
Willett P. Similarity-based virtual screening using 2D fingerprints. Drug Discov Today. 2006;11(23):1046-53doi: 10.1016/j.drudis.2006.10.005.
Willett, P. (2006). Similarity-based virtual screening using 2D fingerprints. Drug discovery today, 11(23), 1046-53. https://doi.org/10.1016/j.drudis.2006.10.005
Willett, Peter. "Similarity-based virtual screening using 2D fingerprints." Drug discovery today vol. 11,23 (2006): 1046-53. doi: https://doi.org/10.1016/j.drudis.2006.10.005
Willett P. Similarity-based virtual screening using 2D fingerprints. Drug Discov Today. 2006 Dec;11(23):1046-53. doi: 10.1016/j.drudis.2006.10.005. Epub 2006 Oct 20. PMID: 17129822.
Copy Download .nbib Format: NLM
Proceedings of the 16th annual conference of the Groupement des Pharmacochimistes de l'Arc Atlantique (GP2A).

Journal of enzyme inhibition and medicinal chemistry

Guillon J, Le Baut G, Le Borgne M.
PMID: 18821248
J Enzyme Inhib Med Chem. 2008 Oct;23(5):587. doi: 10.1080/14756360802204656.

No abstract available.

Cite
Guillon J, Le Baut G, Le Borgne M. Proceedings of the 16th annual conference of the Groupement des Pharmacochimistes de l'Arc Atlantique (GP2A). J Enzyme Inhib Med Chem. 2008;23(5):587doi: 10.1080/14756360802204656.
Guillon, J., Le Baut, G., & Le Borgne, M. (2008). Proceedings of the 16th annual conference of the Groupement des Pharmacochimistes de l'Arc Atlantique (GP2A). Journal of enzyme inhibition and medicinal chemistry, 23(5), 587. https://doi.org/10.1080/14756360802204656
Guillon, Jean, et al. "Proceedings of the 16th annual conference of the Groupement des Pharmacochimistes de l'Arc Atlantique (GP2A)." Journal of enzyme inhibition and medicinal chemistry vol. 23,5 (2008): 587. doi: https://doi.org/10.1080/14756360802204656
Guillon J, Le Baut G, Le Borgne M. Proceedings of the 16th annual conference of the Groupement des Pharmacochimistes de l'Arc Atlantique (GP2A). J Enzyme Inhib Med Chem. 2008 Oct;23(5):587. doi: 10.1080/14756360802204656. PMID: 18821248.
Copy Download .nbib Format: NLM
Efficient medicinal chemistry.

Combinatorial chemistry & high throughput screening

Kyle DJ.
PMID: 16475964
Comb Chem High Throughput Screen. 2006 Feb;9(2):77. doi: 10.2174/138620706775541909.

No abstract available.

Cite
Kyle DJ. Efficient medicinal chemistry. Comb Chem High Throughput Screen. 2006;9(2):77doi: 10.2174/138620706775541909.
Kyle, D. J. (2006). Efficient medicinal chemistry. Combinatorial chemistry & high throughput screening, 9(2), 77. https://doi.org/10.2174/138620706775541909
Kyle, Donald J. "Efficient medicinal chemistry." Combinatorial chemistry & high throughput screening vol. 9,2 (2006): 77. doi: https://doi.org/10.2174/138620706775541909
Kyle DJ. Efficient medicinal chemistry. Comb Chem High Throughput Screen. 2006 Feb;9(2):77. doi: 10.2174/138620706775541909. PMID: 16475964.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries